PAX6 and cataract: In the present studies through analysis of the changes of the non‐sumoylated and sumoylated p32 Pax6 in different groups of cataract patients, we clearly demonstrated that the non‐sumoylated p32 Pax6 is increased in those from 50s to 60s.